TY - JOUR
T1 - The degree of left atrial structural remodeling impacts left ventricular ejection fraction in patients with atrial fibrillation
AU - Akkaya, Mehmet
AU - Marrouche, Nassir
AU - Higuchi, Koji
AU - Koopmann, Matthias
AU - Damal, Kavitha
AU - Kholmovski, Eugene
AU - McGann, Chris
PY - 2014
Y1 - 2014
N2 - Objectives: The extent of left atrial (LA) wall structural remodeling (fibrosis) detected by late gadolinium enhancementmagnetic resonance imaging (LGE-MRI) is correlated with advanced atrial fibrillation (AF). The concomitant occurrence of AF and left ventricular (LV) dysfunction is not uncommon. We studied the effect of LA fibrosis, a confounder of both AF and LV dysfunction, on LV ejection fraction (EF). Study design: For the analysis, we identified and included 384 patients from our retrospective AF database who underwent LGE-MRI and transthoracic echocardiography prior to AF ablation. Based on the degree of LA fibrosis, patients were categorized into four stages as: Utah 1 (<5% LA fibrosis), Utah 2 (5-20% fibrosis), Utah 3 (20-35% fibrosis), and Utah 4 (>35% fibrosis). Results: The average pre-ablation LVEF was 60.5%±8.5% (n=24) in Utah stage 1 patients, 55.7%±10.3% (n=240) in Utah stage 2 patients, 51.7±11.5% (n=90) in Utah stage 3 patients, and 48.9%±11.6% (n=30) in Utah stage 4 patients (p<0.001, one-way ANOVA). The percentage of LA fibrosis was significantly negatively correlated to LVEF pre-ablation in a univariate analysis (p<0.001). In a multivariate model accounting for age, gender, AF type, and comorbidities such as diabetes and hypertension, Utah stage remained a significant predictor of pre-ablation EF (p<0.001). Conclusion: Patients with extensive LA fibrosis appear to have depressed LV function pre-ablation, suggesting that structural remodeling in the LA may also be triggering and promoting remodeling within the ventricular myocardium.
AB - Objectives: The extent of left atrial (LA) wall structural remodeling (fibrosis) detected by late gadolinium enhancementmagnetic resonance imaging (LGE-MRI) is correlated with advanced atrial fibrillation (AF). The concomitant occurrence of AF and left ventricular (LV) dysfunction is not uncommon. We studied the effect of LA fibrosis, a confounder of both AF and LV dysfunction, on LV ejection fraction (EF). Study design: For the analysis, we identified and included 384 patients from our retrospective AF database who underwent LGE-MRI and transthoracic echocardiography prior to AF ablation. Based on the degree of LA fibrosis, patients were categorized into four stages as: Utah 1 (<5% LA fibrosis), Utah 2 (5-20% fibrosis), Utah 3 (20-35% fibrosis), and Utah 4 (>35% fibrosis). Results: The average pre-ablation LVEF was 60.5%±8.5% (n=24) in Utah stage 1 patients, 55.7%±10.3% (n=240) in Utah stage 2 patients, 51.7±11.5% (n=90) in Utah stage 3 patients, and 48.9%±11.6% (n=30) in Utah stage 4 patients (p<0.001, one-way ANOVA). The percentage of LA fibrosis was significantly negatively correlated to LVEF pre-ablation in a univariate analysis (p<0.001). In a multivariate model accounting for age, gender, AF type, and comorbidities such as diabetes and hypertension, Utah stage remained a significant predictor of pre-ablation EF (p<0.001). Conclusion: Patients with extensive LA fibrosis appear to have depressed LV function pre-ablation, suggesting that structural remodeling in the LA may also be triggering and promoting remodeling within the ventricular myocardium.
UR - http://www.scopus.com/inward/record.url?scp=84900396449&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900396449&partnerID=8YFLogxK
U2 - 10.5543/tkda.2014.20726
DO - 10.5543/tkda.2014.20726
M3 - Article
C2 - 24481089
AN - SCOPUS:84900396449
VL - 42
SP - 11
EP - 19
JO - Turk Kardiyoloji Dernegi Arsivi
JF - Turk Kardiyoloji Dernegi Arsivi
SN - 1016-5169
IS - 1
ER -